ethyldimethylaminopropyl carbodiimide has been researched along with sirolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bryant, J; Hlavaty, KA; Luo, X; Shea, LD; Yap, WT; Zhang, L; Zhang, X | 1 |
| Ding, J; Guo, S; Liu, S; Ma, X; Song, B; Song, Y; Su, Y; Xiao, B; Yi, C; Zhang, D | 1 |
2 other study(ies) available for ethyldimethylaminopropyl carbodiimide and sirolimus
| Article | Year |
|---|---|
Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation.
Topics: Animals; Antigens; Drug Carriers; Ethyldimethylaminopropyl Carbodiimide; Immune Tolerance; Immunosuppressive Agents; Islets of Langerhans Transplantation; Male; Mice, Inbred BALB C; Nanoparticles; Polyglactin 910; Sirolimus; Transplantation, Homologous | 2014 |
Transfusion of ethylene carbodiimide-fixed donor splenocytes prolongs survival of vascularized skin allografts.
Topics: Animals; Cell Transplantation; Cytokines; Ethyldimethylaminopropyl Carbodiimide; Graft Rejection; Immunosuppressive Agents; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Sirolimus; Skin Transplantation; Spleen; T-Lymphocytes, Regulatory; Transplantation, Homologous | 2018 |